News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–72
- Matches
- 145
- Sources here
- 18
- Companies here
- 7
Active search
145 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Puma Biotechnology Inc (PBYI) Institutional Confidence
Puma Biotechnology Inc (PBYI) has an institutional shareholding score of 7.00, placing it 50th among 155 companies in the Pharmaceuticals industry. The institutional shareholding proportion is 81.56%, marking a 14.60% quarter-over-quarter increase. James Simons is the largest institutional shareholder, holding 3.82% of outstanding shares.
Mike Ashley’s Frasers Group Launches a Summer Offensive in Europe
LONDON — It's been a frenetic summer for Mike Ashley's Frasers Group, which has launched an offensive on retail brands ranging from Harvey Nichols in the U.K. to Hugo Boss and Puma in Germany. Now, Frasers has raised its stake in Burberry to 4.16 …
PBYI|Puma Biotechnology Inc|Price:7.955|Chg%:-0.035
Puma Biotechnology Inc (PBYI) has strong fundamentals and high growth potential, with its valuation considered fairly valued within the Pharmaceuticals industry. The stock exhibits high institutional ownership and analysts generally rate it as a Hold, with expectations for stable price performance in the medium …
Puma Biotechnology Inc Revenue Breakdown – NASDAQ:PBYI
Puma Biotechnology Inc. (NASDAQ: PBYI) generated 204.10 million USD in revenue last year. Its top-performing segment, Cancer Care Products, contributed 228.37 million USD, which was slightly down from 230.47 million USD the previous year. The United States was the primary source of revenue, accounting …
Is Concrete Pumping Holdings (BBCP) Outperforming Other Business Services Stocks This Year?
Concrete Pumping Holdings (BBCP) is significantly outperforming other Business Services stocks and its specific Waste Removal Services industry year-to-date, with a 56.9% return compared to the sector's -9.2% and the industry's -1.5%. The company holds a Zacks Rank of #1 (Strong Buy), driven by …
Puma Biotechnology Inc (PBYI) Financial Health: Profitability & Balance Sheet Analysis
Puma Biotechnology Inc (PBYI) has a current financial score of 7.61, indicating robust financial status and high operating efficiency, ranking 108 out of 155 in the Pharmaceuticals industry. The company's latest quarterly revenue was $44.81M, showing a 2.59% year-over-year decrease, while net profit decreased …
Puma Biotechnology Inc (PBYI) Dividends & Stock Splits: Historical Payouts and Event Timeline
The article provides a historical overview of dividends and stock splits for Puma Biotechnology Inc (PBYI). It indicates that the company has not distributed any dividends over the past five years, with "No Data" appearing for dividend history. The document also presents current stock …
Puma Biotechnology Inc (PBYI) Shareholder Structure: Major Shareholders & Institutional Holdings
This article provides an overview of Puma Biotechnology Inc's (PBYI) shareholder structure, detailing major individual and institutional holders as of recent updates. It includes a breakdown of shareholder types, institutional shareholding trends over recent quarters, and recent shareholder activity, alongside related ETF holdings.
ETFs Investing in Puma Biotechnology, Inc. Stocks
This article lists various ETFs that hold shares of Puma Biotechnology, Inc. (PBYI). The ETFs are primarily focused on small-cap, value, or biotechnology sectors and include details such as market value, weight of PBYI stock in the fund, issuer, management style, expense ratio, and …
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2026 Financial Results
Puma Biotechnology, Inc. announced it will host a conference call on Thursday, August 6, 2026, at 1:30 p.m. PT/4:30 p.m. ET to discuss its second-quarter 2026 financial results. The call will follow the release of these results and will include a live webcast and …
Puma Biotechnology Inc (PBYI) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Puma Biotechnology Inc (PBYI), detailing its price momentum, support and resistance levels, and various technical indicators. It notes that PBYI's current price momentum score is 3.31, with the stock trading between a resistance level of 8.62 and …
Concrete Pumping stock initiated with buy rating at Texas Capital on data center demand
Texas Capital Securities has initiated coverage on Concrete Pumping Holding Inc (NASDAQ:BBCP) with a buy rating and a price target of $15.00, citing strong growth potential from data centers, semiconductor plants, and infrastructure spending. Despite the analyst's positive outlook, InvestingPro data suggests the stock …
Puma Exploration's Inaugural Drilling Confirms High-Grade Gold System at McKenzie
Rimouski, Québec--(Newsfile Corp. - July 21, 2026) - Puma Exploration Inc. (TSXV: PUMA) (OTCQB: PUMXF) ("Puma" or the "Company") is pleased to announce assay results from its inaugural 2,721-metre diamond drilling program at the RIM Gold Zone of its McKenzie Gold Project in Northern …
Concrete Pumping Holdings, Inc. SEC Filing (Jul 17, 2026)
This article reports on Concrete Pumping Holdings, Inc.'s SEC filing, specifically an EFFECT filing for a Form S-3, with an effectiveness date of July 16, 2026, at 4:00 PM. The filing is deemed neutral in impact and sentiment by Rhea-AI. The article also provides …